×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Markets
Markets
FII & DII Activity
Corporate Action
Research Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Stock Updates
PRO Stock Lists
Monsoon Tracker
Seasonality Analysis
Crypto Dashboard
Web Stories
Tax Calculator
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Invest in Unlisted Shares
Specials
Pharma Industry Conclave
Unlocking opportunities in Metal and Mining
#MFSummit2025
Moneycontrol mutual fund summit 2025
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
Personal Finance
Forum
Videos
you are here:
Home
News
Wockhardt
Wockhardt
Ads
Wockhardt Standalone September 2025 Net Sales at Rs 380.00 crore, up 2.7% Y-o-Y
Wockhardt Consolidated September 2025 Net Sales at Rs 782.00 crore, down 3.34% Y-o-Y
Wockhardt applies to seek USFDA nod for ‘miracle’ antibiotic Zaynich
Drug maker Wockhardt rallies over 9 percent as White House exempts pharma imports from nations with trade pacts
Wockhardt Standalone June 2025 Net Sales at Rs 413.00 crore, up 17.33% Y-o-Y
Wockhardt shares rally over 5 percent after Zaynich used to treat pan-drug resistant infection
Stocks to Watch Today: DMart, NCC, Kolte Patil, VIP Industries, Sula Vineyards, Wockhardt, Akzo Nobel, Gland Pharma, Travel Food Services in focus on 14 July
Wockhardt to exit US generic pharma segment to unlock capital for high-impact areas
Wockhardt shares jump 8% amid high trading volumes, pharma stock extends gains to 45% in one month
Wockhardt Consolidated March 2025 Net Sales at Rs 743.00 crore, up 6.14% Y-o-Y
Trade Spotlight: How should you trade CDSL, Manappuram Finance, Wockhardt, HDFC Life Insurance, GSK Pharma and others on June 2?
Wockhardt shares jump 7% as net loss narrows to Rs 45 crore in Q4FY25
Wockhardt Zaynich succeeds in third compassionate use, shares rise while tariff talk keeps pharma subdued
Wockhardt Consolidated December 2024 Net Sales at Rs 721.00 crore, up 2.85% Y-o-Y
Wockhardt Standalone December 2024 Net Sales at Rs 325.00 crore, up 12.85% Y-o-Y
Wockhardt returns to the black with Rs 14 crore net profit in Q3, revenue rises 3%
Trade Spotlight: How should you trade Tata Motors, Larsen and Toubro, Amber Enterprises, Concord Biotech, Wockhardt, and others on February 5?
Wockhardt shares up 10% after Zaynich achieves 96.8% efficacy in Phase III study
Wockhardt shares rally 5% after Indian drug regulator approves Pneumonia antibiotic
Stocks to Watch Today: Bharti Airtel, Hero MotoCorp, Biocon, Wockhardt, RITES, DMart, V2 Retail, Bank of Maharashtra in focus on 3 January
Trade Spotlight: How should you trade HDFC Life, HUL, Piccadilly Agro, Jindal Photo, Wockhardt, SRM Contractors, and others on Tuesday?
Wockhardt rises 10% after antibiotic Zaynich, undergoing clinical trials, facilitates in a liver transplant
Wockhardt Consolidated September 2024 Net Sales at Rs 809.00 crore, up 7.44% Y-o-Y
Wockhardt Standalone September 2024 Net Sales at Rs 370.00 crore, up 42.31% Y-o-Y
Wockhardt shares rise 2% as Q2FY25 net loss narrows to Rs 16 crore
View More
Home
Markets
Loans
SPIN
2
WIN
News
Portfolio